全球血管內動脈瘤修復設備市場規模（按產品類型、動脈瘤類型、最終用戶、地區、範圍和預測）

血管內動脈瘤修復設備的市場規模及預測

血管內動脈瘤修復設備市場規模預計在2023 年將達到26.47 億美元，在2024 年至2030 年的預測期內以4.9% 的複合年增長率增長，到2030 年將達到43 億美元。預計達到6000萬美元。血管內動脈瘤修復設備市場包括各種專門設計用於微創治療血管系統內動脈瘤的醫療設備和技術。這些裝置用於血管內手術，修復血管的薄弱部分，降低破裂風險和可能危及生命的併發症。

血管內動脈瘤修復（EVAR）裝置包括支架移植物、導管、導絲和其他相關工具，用於加固和穩定受影響的血管，而無需進行開放性手術。

血管內動脈瘤修復設備的全球市場驅動因子

血管內動脈瘤修復設備市場的市場推動因素可能受到多種因素的影響。

主動脈瘤的盛行率

推動全球 EVAR 設備市場發展的主要因素之一是主動脈瘤發生率的上升。由於生活方式的改變和人口老化，主動脈瘤，尤其是腹主動脈瘤 (AAA) 的發生率正在增加，因此需要有效的治療方案。

技術開發：

隨著血管內治療技術和設備的技術發展，主動脈瘤的治療選擇正在不斷擴大。由於支架移植物、輸送方法和影像技術等技術創新，EVAR 手術的安全性和有效性正在提高，有助於推動市場擴張。

微創：

與開放手術相比，EVAR 手術具有創傷性較小、住院時間更短、恢復時間更快、發病率和死亡率更低等優點。患者和醫生對微創手術的偏好日益增加，推動了 EVAR 的需求。

老年人口不斷增加：

隨著患者年齡的增長，他們更容易患主動脈瘤，對 EVAR 設備的需求也隨之增加。全球人口老化，尤其是已開發國家人口老化，推動了對有效主動脈瘤治療的需求，這有助於擴大市場。

政府措施與醫療改革：

EVAR 設備的採用是由政府旨在加強醫療保健系統和擴大獲得尖端醫療服務機會的舉措所推動的。鼓勵血管內治療的報銷指南和醫療改革也推動了市場擴張。

宣傳與篩檢計畫活動：

由於公眾對主動脈瘤的認識以及透過篩檢計畫進行早期發現的價值不斷提高，患者數量的增加和對 EVAR 治療的需求正在推動市場擴張。

夥伴關係與合作關係：

透過與研究中心、醫療設備製造商和醫療保健提供者合作促進創新，我們開發了尖端的 EVAR 技術。策略合作夥伴關係還可以幫助我們利用互補的能力和資源來擴大市場。

在新興市場擴張：

亞太、拉丁美洲、中東等新興國家醫療基礎建設發達、可支配收入不斷上升、對前沿醫療的認知度不斷提升，具有巨大的市場發展潛力。

限制全球血管內動脈瘤修復設備市場的因素

有幾個因素可能會對血管內動脈瘤修復設備市場造成限製或課題。

EVAR 手術費用高：

考慮到設備、住院時間和術後護理，EVAR 手術的費用可能很高。 EVAR 的高成本可能會限制其使用，尤其是在醫療預算緊張或報銷率低的地區。

長期耐用性問題：

儘管 EVAR 技術取得了進步，但關於長期可行性和潛在副作用（包括內漏、移植物移位和設備相關感染）的問題仍然存在。這些因素可能會影響患者的治療結果，並阻止醫生和患者選擇 EVAR 而不是開放性手術。

缺乏熟練的介入醫師：

進行 EVAR 治療需要血管外科或介入放射學的特殊知識和訓練。訓練有素的干預人員的短缺，尤其是在偏遠和貧困地區，可能會限制患者接受 EVAR 治療並阻礙市場擴張。

監理課題與審批延遲：

EVAR 設備的監管審批是一個漫長而複雜的過程，涉及嚴格的臨床試驗和監管提交。獲得新產品批准或對現有產品進行修改的延遲可能會阻礙市場進入和創新並減緩市場成長。

不良事件與再次介入的風險：

雖然內視鏡靜脈移植術（EVAR）治療通常比開放性手術創傷性更小，但內漏、移植失敗等問題始終存在。解決這些問題可能需要修復手術，這會增加醫療成本並對患者的生活品質產生負面影響。因此，患者可能不願意接受 EVAR 治療。

兌換範圍有限：

某些醫療保健系統可能會透過嚴格的資格要求或報銷政策來限制病患的就醫機會，而這些保單不能完全涵蓋 EVAR 手術的費用。報銷不足可能會阻礙市場擴張，尤其是在自付費用較高的地區。

替代療法：

主動脈瘤的替代療法，例如開放式手術修復和影像監測隨訪，對於某些患者群體來說仍然適用。獲得此類替代療法可能會影響 EVAR 設備的採用和市場成長。

經濟不確定性與市場波動：

投資選擇和醫療保健支出可能會受到經濟衰退、地緣政治不穩定和醫療保健政策變化帶來的市場不確定性和波動的影響。市場動態可能會受到影響患者支付 EVAR 治療費用的能力和醫院採購決策的經濟問題的影響。

目錄

第 1 章簡介

• 市場定義
• 市場區隔
• 研究方法

第 2 章執行摘要

• 主要發現 市場概況
• 市場亮點

第3章 市場概覽

• 市場規模與成長潛力
• 市場趨勢
• 市場推動因素
• 市場限制
• 市場機會
• 波特五力分析

第4章 血管內動脈瘤修復設備市場（依產品類型）

• 主動脈支架移植物
• 導管
• 導絲
• 血管內動脈瘤修復 (EVAR) 系統

第 5 章 血管內動脈瘤修復設備市場（按動脈瘤類型）

• 腹主動脈瘤 (AAA)
• 胸主動脈瘤 (TAA)
• 週邊動脈瘤

第6章 血管內動脈瘤修復設備市場（依最終用戶）

• 醫院
• 門診手術中心
• 專科診所

第 7 章 區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利 亞太地區
• 中國
• 日本
• 印度
• 澳大利亞
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第 8 章 市場動態

• 市場推動因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第 9 章 競爭格局

• 大型公司
• 市佔率分析

第10章 公司簡介

• Medtronic plc
• Cook Medical Group
• Abbott Laboratories
• Becton, Dickinson and Company
• Cardinal Health Inc.
• Endologix, Inc.
• Lombard Medical Technologies plc
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Getinge AB

第 11 章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第 12 章附錄

• 縮寫列表
• 來源與參考文獻

Endovascular Aneurysm Repair Devices Market Size And Forecast

Endovascular Aneurysm Repair Devices Market size was valued at USD 2647 Million in 2023 and is projected to reach USD 4360 Million by 2030 , growing at a CAGR of 4.9% during the forecast period 2024 to 2030. The Endovascular Aneurysm Repair Devices Market encompasses a range of medical devices and technologies designed for the minimally invasive treatment of aneurysms, particularly within the vascular system. These devices are utilized in endovascular procedures to repair weakened areas of blood vessels, thereby reducing the risk of rupture and potentially life-threatening complications.

Endovascular aneurysm repair (EVAR) devices include stent grafts, catheters, guidewires, and other related tools used to reinforce and stabilize the affected blood vessel without the need for open surgery.

Global Endovascular Aneurysm Repair Devices Market Drivers

The market drivers for the Endovascular Aneurysm Repair Devices Market can be influenced by various factors. These may include:

Prevalence of Aortic Aneurysms:

One major factor propelling the global market for EVAR devices is the rising incidence of aortic aneurysms. Effective treatment options are required since the incidence of aortic aneurysms, especially abdominal aortic aneurysms (AAA), is increasing due to changes in lifestyle and aging of the population.

Technological developments:

Technological developments in endovascular procedures and equipment have resulted in an expansion of treatment options for aortic aneurysms. The safety and effectiveness of EVAR operations have been enhanced by innovations like stent grafts, delivery methods, and imaging technologies, which have propelled market expansion.

Minimally Invasive Nature:

When EVAR procedures are performed instead of open surgery, they are less invasive and come with advantages like shorter hospital stays, quicker recovery times, and lower rates of morbidity and death. The demand for EVAR devices is being driven by patients' and doctors' increased preference for minimally invasive procedures.

Growing Senior Population:

As people age, they become more vulnerable to aortic aneurysms, which increases the need for EVAR devices. Growing worldwide, especially in developed nations, is the aging population, which raises the need for efficient aortic aneurysm treatment alternatives and propels market expansion.

Government Initiatives and Healthcare Reforms:

The adoption of EVAR devices is being driven by government initiatives aimed at enhancing the healthcare system and expanding access to cutting-edge medical treatments. Market expansion is also facilitated by reimbursement guidelines and healthcare reforms that encourage endovascular procedures.

Campaigns for Awareness and Screening Programs:

By driving up patient numbers and demand for EVAR treatments, initiatives to increase public knowledge of aortic aneurysms and the value of early detection through screening programs support market expansion.

Partnerships and Collaborations:

Research centers, medical device manufacturers, and healthcare providers work together to develop cutting-edge EVAR technology by promoting innovation. By utilizing complementary capabilities and resources, strategic partnerships also aid in market expansion.

Expansion in Emerging Markets:

Areas like Asia-Pacific, Latin America, and the Middle East offer substantial prospects for market growth due to the developing healthcare infrastructure in these countries, as well as rising disposable income and rising awareness of cutting-edge medical treatments.

Global Endovascular Aneurysm Repair Devices Market Restraints

Several factors can act as restraints or challenges for the Endovascular Aneurysm Repair Devices Market. These may include:

Exorbitant Cost of EVAR Procedures:

The price of EVAR procedures can be high, taking into account the devices, the hospital stay, and the aftercare. Because of its high cost, EVAR therapies may not be as widely available, especially in areas with tight healthcare budgets or low reimbursement.

Problems with Long-Term Sturdiness Concerns:

Although EVAR technology has advanced, questions still exist about its long-term viability and possible side effects such endoleaks, graft migration, and infections from the device. These elements may have an impact on patient outcomes and discourage doctors and patients from choosing EVAR over open surgery.

Scarce Skilled Interventionalists:

To execute EVAR treatments, one needs specific knowledge and training in either vascular surgery or interventional radiology. The scarcity of trained interventionists, especially in remote or underprivileged locations, can limit patient access to EVAR therapies and impede the expansion of the market.

Regulatory Difficulties and Approval Delays:

EVAR device regulatory approval can be obtained through a protracted and intricate process that includes stringent clinical trials and regulatory filings. Market entry and innovation might be hindered by delays in getting approvals for new products or modifications to current ones, which can slow down the growth of the market.

Risk of Adverse Events and Reinterventions:

Although endoscopic vein grafting (EVAR) treatments are typically less invasive than open surgery, there is always a chance of problems including endoleak or graft failure. Reinterventions may be necessary to address these issues, which could raise healthcare expenditures and negatively affect patient quality of life. As a result, patients may be reluctant to use EVAR treatments.

Limited Reimbursement Coverage:

In certain healthcare systems, patient access may be restricted by rigorous eligibility requirements or by reimbursement policies that do not sufficiently cover the expenses of EVAR procedures. Market expansion may be hampered by inadequate reimbursement, especially in areas where out-of-pocket costs are high.

Alternative Therapies:

For some patient populations, alternative therapies for aortic aneurysms, such as open surgical repair or watchful waiting along with imaging surveillance, are still appropriate. These substitutes' accessibility may have an impact on EVAR device adoption as well as market expansion.

Economic Uncertainty and Market Volatility:

Investment choices and healthcare spending can be impacted by market uncertainty and volatility brought about by economic downturns, geopolitical unrest, and changes in healthcare policy. Market dynamics may be impacted by economic issues that affect patients' ability to pay for EVAR treatments and hospitals' purchasing decisions.

Global Endovascular Aneurysm Repair Devices Market Segmentation Analysis

The Global Endovascular Aneurysm Repair Devices Market is segmented based on Product Type, Aneurysm Type, End User And Geography.

Endovascular Aneurysm Repair Devices Market, By Product Type

• Aortic Stent Grafts:
• Stent grafts designed specifically for the endovascular repair of aortic aneurysms, providing a minimally invasive alternative to open surgery.
• Catheters:
• Flexible tubes used for various diagnostic and interventional procedures, including guiding other medical devices such as stent grafts during endovascular aneurysm repair.
• Guidewires:
• Thin, flexible wires used to guide catheters and other medical devices through the blood vessels to reach the treatment site accurately.
• Endovascular Aneurysm Repair (EVAR) Systems:
• Comprehensive systems including devices such as stent grafts, catheters, and guidewires, designed to facilitate the minimally invasive repair of aortic aneurysms.

Endovascular Aneurysm Repair Devices Market, By Aneurysm Type

• Abdominal Aortic Aneurysms (AAA):
• Aneurysms occurring in the abdominal portion of the aorta, which can be treated using various endovascular techniques.
• Thoracic Aortic Aneurysms (TAA):
• Aneurysms affecting the thoracic portion of the aorta, often requiring specialized stent grafts for endovascular repair.
• Peripheral Aneurysms:
• Aneurysms found in peripheral arteries outside of the aorta, requiring tailored endovascular approaches for treatment.

Endovascular Aneurysm Repair Devices Market, By End User

• Hospitals:
• Facilities equipped with the infrastructure and expertise to provide comprehensive medical care, including the diagnosis and treatment of aortic aneurysms using endovascular devices.
• Ambulatory Surgical Centers:
• Outpatient facilities specializing in performing surgical procedures, including minimally invasive endovascular aneurysm repair, with shorter recovery times compared to traditional hospitals.
• Specialty Clinics:
• Clinics focusing on specific medical specialties, such as vascular surgery or interventional radiology, providing targeted care for patients requiring endovascular treatment for aneurysms.

Endovascular Aneurysm Repair Devices Market, By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Key Players

• The major players in the Endovascular Aneurysm Repair Devices Market are:
• Medtronic plc
• Cook Medical Group
• Abbott Laboratories
• Becton Dickinson and Company
• Cardinal Health Inc.
• Endologix Inc.
• Lombard Medical Technologies plc
• Terumo Corporation
• L. Gore & Associates Inc.
• Getinge AB

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Endovascular Aneurysm Repair Devices Market, By Product Type

• Aortic Stent Grafts
• Catheters
• Guidewires
• Endovascular Aneurysm Repair (EVAR) Systems

5. Endovascular Aneurysm Repair Devices Market, By Aneurysm Type

• Abdominal Aortic Aneurysms (AAA)
• Thoracic Aortic Aneurysms (TAA)
• Peripheral Aneurysms

6. Endovascular Aneurysm Repair Devices Market, By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Medtronic plc
• Cook Medical Group
• Abbott Laboratories
• Becton, Dickinson and Company
• Cardinal Health Inc.
• Endologix, Inc.
• Lombard Medical Technologies plc
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Getinge AB

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References